IMPAX Comments on Wyeth's Lawsuit Related to Generic Versions of Effexor XR(R) (RedNova)
IMPAX Laboratories, Inc. (OTC: IPXL) today anno

Pharmaceutical, Healthcare & Life Sciences (Mondaq)
2005 saw only seventeen biotechs enter the public markets, raising a total of $813 million from their IPOs a 50% drop from the amount raised in 2004. (Source: Burrill & Company) A number of these newly public companies are now trading below the IPO share price.